Safety & efficacy of single subconjunctival triamcinolone 5 mg depot vs topical loteprednol post cataract surgery: less drop cataract surgery
详细信息    查看全文 | 推荐本文 |
  • 英文篇名:Safety & efficacy of single subconjunctival triamcinolone 5 mg depot vs topical loteprednol post cataract surgery: less drop cataract surgery
  • 作者:Jagadeesh ; Kumar ; Reddy ; Vivek ; Chaitanya ; Neeraj ; Shah ; Venkata ; Prabhakar ; Guduru ; Shadab ; Khan ; Siddharthan ; Kuttupalayam
  • 英文作者:Jagadeesh Kumar Reddy;Vivek Chaitanya;Neeraj Shah;Venkata Prabhakar Guduru;Shadab Khan;Siddharthan Kuttupalayam;Department of Cornea,Sankara Eye Hospital;
  • 英文关键词:intraocular pressure;;subconjunctival triamcinolone acetonide;;phacoemulsification;;loteprednol;;cells/flare;;less drop cataract surgery
  • 中文刊名:GYZZ
  • 英文刊名:国际眼科杂志(英文版)
  • 机构:Department of Cornea,Sankara Eye Hospital;
  • 出版日期:2019-05-15 14:14
  • 出版单位:International Journal of Ophthalmology
  • 年:2019
  • 期:v.12
  • 语种:英文;
  • 页:GYZZ201905012
  • 页数:5
  • CN:05
  • 分类号:84-88
摘要
AIM: To do a randomized prospective interventional study for comparing the effects of a single subconjunctival triamcinolone acetonide(SCTA) injection to tapering topical loteprednol in patients undergoing phacoemulsification surgery under topical anesthesia. METHODS: A total of 400 patients were randomized into 2 groups; Group A(200 patients) received 5 mg SCTA at the end of surgery and topical ketorolac tromethamine(0.5%) with ofloxacin(0.3%) combination for 3 wk. Group B(200 patients) received tapering topical loteprednol etabonate(0.5%) along with ofloxacin(0.3%) and ketorolac tromethamine(0.5%) for 3 wk. Outcomes evaluated were intraocular pressure(IOP), anterior chamber cells/flare and macular oedema postoperatively at 1, 6 and 12 wk.RESULTS: Baseline parameters were almost similar in both the groups. No statistical difference was seen between the preoperative and postoperative IOP values for Group A(P=0.82) and Group B(P=0.61) and postoperative IOP values in between both groups(P=0.14) at 1 wk. Incidence of cells/flare postoperative was statistically not significant(P=0.82) in both groups at all follow up visits. Postoperative macular oedema was not observed at any follow up visit. CONCLUSION: SCTA appears to be an effective alternative to prolong postoperative topical steroid use.
        AIM: To do a randomized prospective interventional study for comparing the effects of a single subconjunctival triamcinolone acetonide(SCTA) injection to tapering topical loteprednol in patients undergoing phacoemulsification surgery under topical anesthesia. METHODS: A total of 400 patients were randomized into 2 groups; Group A(200 patients) received 5 mg SCTA at the end of surgery and topical ketorolac tromethamine(0.5%) with ofloxacin(0.3%) combination for 3 wk. Group B(200 patients) received tapering topical loteprednol etabonate(0.5%) along with ofloxacin(0.3%) and ketorolac tromethamine(0.5%) for 3 wk. Outcomes evaluated were intraocular pressure(IOP), anterior chamber cells/flare and macular oedema postoperatively at 1, 6 and 12 wk.RESULTS: Baseline parameters were almost similar in both the groups. No statistical difference was seen between the preoperative and postoperative IOP values for Group A(P=0.82) and Group B(P=0.61) and postoperative IOP values in between both groups(P=0.14) at 1 wk. Incidence of cells/flare postoperative was statistically not significant(P=0.82) in both groups at all follow up visits. Postoperative macular oedema was not observed at any follow up visit. CONCLUSION: SCTA appears to be an effective alternative to prolong postoperative topical steroid use.
引文
1 Watson D,Noble MJ,Dutton GN,Midgley JM,Healey TM.Penetration of topically applied dexamethasone alcohol into human aqueous humor.Arch Ophthalmol 1988;106(5):686-687.
    2 Chang DF,Wong V.Two clinical trials of an intraocular steroid delivery system for cataract surgery.Trans Am Ophthalmol Soc 1999;97:261-279.
    3 Helm CJ,Holland GN.The effects of posterior subtenon injection of triamcinolone acetonide in patients with intermediate uveitis.Am JOphthalmol 1995;120(1):55-64.
    4 Zamir E,Read RW,Smith RE,Wang RC,Rao NA.A prospective evaluation of subconjunctival injection of triamcinolone acetonide for resistant anterior scleritis.Ophthalmology 2002;109(4):798-805;discussion805-807.
    5 Flach AJ,Jaffe NS,Akers WA.The effect of ketorolac tromethamine in reducing postoperative inflammation:double-mask parallel comparison with dexamethasone.Ann Ophthalmol 1989;21(11):407-411.
    6 Cervantes-Coste G,Sánchez-Castro YG,Orozco-Carroll M,MendozaSchuster E,Velasco-Barona C.Inhibition of surgically induced miosis and prevention of postoperative macular edema with nepafenac.Clin Ophthalmol 2009;3:219-226.
    7 Diestelhorst M,Aspacher F,Konen W,Krieglstein GK,Hilgers RD.Effect of dexamethasone 0.1%and prednisolone acetate 1.0%eye drops on the blood-aqueous barrier after cataract surgery:a controlled randomized fluorophotometric study.Graefes Arch Clin Exp Ophthalmol1992;230(5):451-453.
    8 Tsai JC.A comprehensive perspective on patient adherence to topical glaucoma therapy.Ophthalmology 2009;116(11 Suppl):S30-S36.
    9 Hall NF,Lempert P,Shier RP,Zakir R,Phillips D.Grading nuclear cataract:reproducibility and validity of a new method.Br J Ophthalmol1999;83(10):1159-1163.
    10 Jabs DA,Nussenblatt RB,Rosenbaum JT,Standardization of Uveitis Nomenclature(SUN)Working Group.Standardization of uveitis nomenclature for reporting clinical data.Results of the First International Workshop.Am J Ophthalmol 2005;140(3):509-516.
    11 Weijtens O,Schoemaker RC,Romijn FP,Cohen AF,Lentjes EG,van Meurs JC.Intraocular penetration and systemic absorption after topical application of dexamethasone disodium phosphate.Ophthalmology2002;109(10):1887-1891.
    12 Herschler J.Increased intraocular pressure induced by repository corticosteroids.Am J Ophthalmol 1976;82(1):90-93.
    13 Akduman L,Kolker AE,Black DL,Del Priore LV,Kaplan HJ.Treatment of persistent glaucoma secondary to periocular corticosteroids.Am J Ophthalmol 1996;122(2):275-277.
    14 Shah SM,Spalton DJ.Changes in anterior chamber flare and cells following cataract surgery.Br J Ophthalmol 1994;78(2):91-94.
    15 el-Maghraby A,Marzouki A,Matheen TM,Souchek J,Van der Karr M.Reproducibility and validity of laser flare/cell meter measurements as an objective method of assessing intraocular inflammation.Arch Ophthalmol 1992;110(7):960-962.
    16 Tan DT,Chee SP,Lim L,Lim AS.Randomized clinical trial of a new dexamethasone delivery system(Surodex)for treatment of post-cataract surgery inflammation.Ophthalmology 1999;106(2):223-231.
    17 Negi AK,Browning AC,Vernon SA.Single perioperative triamcinolone injection versus standard postoperative steroid drops after uneventful phacoemulsification surgery:Randomized controlled trial.J Cataract Refract Surg 2006;32(3):468-474.
    18 Kim SJ,Belair ML,Bressler NM,Dunn JP,Thorne JE,Kedhar SR,Jabs DA.A method of reporting macular edema after cataract surgery using optical coherence tomography.Retina 2008;28(6):870-876.
    19 Kim SJ,Equi R,Bressler NM.Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography.Ophthalmology 2007;114(5):881-889.
    20 Hee MR,Puliafito CA,Wong C,Duker JS,Reichel E,Rutledge B,Schuman JS,Swanson EA,Fujimoto JG.Quantitative assessment of macular edema with optical coherence tomography.Arch Ophthalmol1995;113(8):1019-1029.
    21 Rotsos TG,Moschos MM.Cystoid macular edema.Clin Ophthalmol2008;2(4):919-930.
    22 Rubinstein A,Hanson RJ,Chen SD,Porter N,Downes SM.Conjunctival ischaemia subsequent to posterior subtenon’s triamcinolone acetonide injection.Eye(Lond)2006;20(3):388-389.
    23 Agrawal S,Agrawal J,Agrawal TP.Conjunctival ulceration following triamcinolone injection.Am J Ophthalmol 2003;136(3):539-540.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.